The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
The growing demand for immune checkpoint inhibitors is mainly driven by the rising incidence of lung cancer, the increasing prevalence of melanoma, and the expanding number of research studies related ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...
The National Agency for Food and Drug Administration and Control (NAFDAC) says it has uncovered large consignments of ...
The National Agency for Food and Drug Administration and Control has uncovered a massive stockpile of falsified and ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...
The FTSE 100 and European stocks were mixed at the open on Monday, as traders digest the potential of escalating tensions ...
Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback